Hansa Biopharma Logo

Hansa Biopharma

HNSA | XSTO

Overview

Corporate Details

ISIN(s):
SE0002148817 (+1 more)
LEI:
549300LLEO25ZJJ3NT91
Country:
Sweden
Address:
Box 785, 220 07 Lund
Sector:
Health Care
Industry:
Biotechnology

Description

Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company. Our vision is a world where all patients with rare immunologic diseases can lead long and healthy lives. But we often see that people with rare diseases are relegated to the impossible and left to fend for themselves. That’s not the way forward. We see all patients as equal individuals with individual needs. A point of view that gives us a unique ability to deliver the most inclusive care to everyone. For us the mission is clear – we want to develop lifesaving and life altering therapies to those who need them the most. And ultimately, we can – and will – eliminate rare diseases, one patient at a time. So how do we aim to achieve our goal? • We partner with global scientific, medical, and patient communities to identify the most urgent needs • We work relentlessly to meet the needs and create lifesaving treatments • Our lead program enables kidney transplantation in difficult-to-transplant patients

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-26 18:40
Regulatory News Service
Hansa Biopharma plans restructuring to optimize resource allocation and improve…
English 220.5 KB
2025-05-26 18:40
Regulatory News Service
Hansa Biopharma planerar omstrukturering för att optimera resursfördelning och …
Swedish 204.8 KB
2025-05-26 07:00
Proxy Solicitation & Information Statements
Notice to Annual General Meeting in Hansa Biopharma AB (publ)
English 206.6 KB
2025-05-26 07:00
General Meeting Notice
Kallelse till årsstämma i Hansa Biopharma AB (publ)
Swedish 461.9 KB
2025-04-24 08:00
Interim Report
Swedish 1.8 MB
2025-04-24 08:00
Interim Report
English 1.6 MB
2025-04-24 07:00
Board/Management Change
Hansa Biopharma appoints new Chief Executive Officer
English 178.1 KB
2025-04-24 07:00
Board/Management Change
Hansa Biopharma utser ny VD
Swedish 185.4 KB
2025-03-21 15:01
Annual Report
Swedish 2.2 MB
2025-03-21 15:01
Annual Report
English 2.2 MB
2025-02-06 07:00
Annual Report
Swedish 1.6 MB
2025-02-06 07:00
Annual Report
English 1.4 MB
2024-12-17 21:40
Earnings Release
Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 stu…
English 162.0 KB
2024-12-17 21:40
Earnings Release
Hansa Biopharma meddelar positiva fullständiga resultat från fas 2-studien 15-H…
Swedish 222.7 KB
2024-10-17 07:00
Earnings Release
Swedish 1.6 MB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-06-17 Anne Säfström Lanner Other Sell 10,487 443,285.49 SEK
2024-06-17 Sören Tulstrup Other Sell 9,199 388,841.73 SEK
2024-06-17 Sören Tulstrup Other Buy 35,200 N/A
2022-07-19 Peter Nicklin Other Buy 14,500 1,032,192.68 SEK
2022-06-17 Christian Kjellman Other Buy 6,915 345,680.85 SEK
2022-06-17 Donato Spota Other Sell 4,638 231,853.62 SEK
2022-06-17 Christian Kjellman Other Sell 4,002 200,059.98 SEK
2022-06-17 Sören Tulstrup Other Sell 3,925 196,210.75 SEK
2022-06-17 Sören Tulstrup Other Buy 3,925 196,210.75 SEK
2022-06-17 Anne Säfström Lanner Other Sell 2,685 134,223.15 SEK

Peer Companies

Company Country Ticker View
ANIMALCARE GROUP PLC Logo ANIMALCARE GROUP PLC United Kingdom ANCR
Annexin Pharmaceuticals AB Logo Annexin Pharmaceuticals AB Sweden ANNX
Apontis Pharma AG Logo Apontis Pharma AG Germany APPH
Aptahem AB Logo Aptahem AB Sweden APTA
Arctic Bioscience Logo Arctic Bioscience Norway ABS
ArcticZymes Technologies Logo ArcticZymes Technologies Norway AZT
argenx SE Logo argenx SE Netherlands (Kingdom of the) 1AE
ARIX BIOSCIENCE PLC Logo ARIX BIOSCIENCE PLC United Kingdom ARIX
AroCell AB Logo AroCell AB Sweden AROC
Arterra Bioscience Logo Arterra Bioscience Italy ABS